Literature DB >> 10447460

The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

M Y Aksenov1, H M Tucker, P Nair, M V Aksenova, D A Butterfield, S Estus, W R Markesbery.   

Abstract

In this study, changes of the expression of two mitochondrial and two nuclear genes encoding the subunits of cytochrome c oxidase (CO) and NADH dehydrogenase (ND) were studied in the hippocampus, inferior parietal lobule, and cerebellum of 10 Alzheimer's disease (AD) and 10 age-matched control subjects. The altered proportion between CO II and CO IV mRNAs was observed in the AD brain. Changes of the proportion between CO II and CO IV transcripts may contribute to the kinetic perturbation of CO documented in AD. A coordinated decrease of ND4 and ND15 mRNAs was found in the AD hippocampus and inferior parietal lobule, but not in cerebellum. The decrease of ND4 gene expression may lead to the inhibition of normal ubiquinone oxidoreductase activity of ND. This study suggests that changes of the expression of mitochondrial and nuclear genes, encoding parts of ND and CO enzyme complexes, may contribute to alterations of oxidative metabolism in AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447460     DOI: 10.1023/a:1020783614031

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  52 in total

Review 1.  Structure and assembly of cytochrome c oxidase.

Authors:  R A Capaldi
Journal:  Arch Biochem Biophys       Date:  1990-08-01       Impact factor: 4.013

Review 2.  Cytochrome c oxidase: structure, function, and membrane topology of the polypeptide subunits.

Authors:  C E Cooper; P Nicholls; J A Freedman
Journal:  Biochem Cell Biol       Date:  1991-09       Impact factor: 3.626

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

5.  Differential susceptibility of human skeletal muscle proteins to free radical induced oxidative damage: a histochemical, immunocytochemical and electron microscopical study in vitro.

Authors:  J W Haycock; P Jones; J B Harris; D Mantle
Journal:  Acta Neuropathol       Date:  1996-10       Impact factor: 17.088

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

Review 8.  Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease.

Authors:  K Chandrasekaran; K Hatanpää; D R Brady; S I Rapoport
Journal:  Exp Neurol       Date:  1996-11       Impact factor: 5.330

Review 9.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

10.  Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.

Authors:  H Schägger; T G Ohm
Journal:  Eur J Biochem       Date:  1995-02-01
View more
  30 in total

1.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

Review 2.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

3.  Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.

Authors:  Fanggeng Zou; Rangaraj K Gopalraj; Johann Lok; Haiyan Zhu; I-Fang Ling; James F Simpson; H Michael Tucker; Jeremiah F Kelly; Samuel G Younkin; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; David A Bennett; Julia E Crook; Steven G Younkin; Steven Estus
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

Review 4.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 5.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 6.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

7.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Socially responsive effects of brain oxidative metabolism on aggression.

Authors:  Hongmei Li-Byarlay; Clare C Rittschof; Jonathan H Massey; Barry R Pittendrigh; Gene E Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

10.  Mitochondria, cognitive impairment, and Alzheimer's disease.

Authors:  M Mancuso; V Calsolaro; D Orsucci; C Carlesi; A Choub; S Piazza; G Siciliano
Journal:  Int J Alzheimers Dis       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.